 |
Macrogen Corp. (U.S.A)
Address : 9700 Great Seneca
Highway, Rockville, MD 20850
TEL: +1-301-251-1007 /FAX
:+1-301-251-1007
|
|
Attributed by the rapid rise in its export, MACROGEN founded a new corporation in the US, named MACROGEN Corporation, in late 2004 and has begun providing services for the regional ( local) customers.
The company is actively engaged in obtaining large-scaled projects by establishing direct contacts with major customers in the region(area). In addition, the company has also established a network with the local researchers and companies in order to understand the industrial trends better and discover prospective businesses.
As the company began to provide genetic analysis services in the Northeast region(area) of the US in August, 2006, the sales is expected to grow consistently and the area of services is also to expanding at a remarkable rate.
|
| |
 |
Macrogen Corp. Japan
Address : Tokyo University of Agriculture, No.11 Building 3F.,
1-1-1 Sakuragaoka, Setagaya-Ku, Tokyo, 156-8502, Japan
TEL: +81-3-5799-4788 /FAX
:+81-3-5799-4771
E-mail : customer@macrogen-japan.co.jp
Website : www.macrogen-japan.co.jp
|
|
| |
 |
Macrogen Corp. Japan
Address : Prof.J.H.Bavinclaan 5 1183AT Amstelveen, The Netherlands
TEL: +31-20-545-3346, 3347 /Mobile
:+31-6-8148-0760
E-mail : europe@macrogen.com
|
|
| |
MACROGEN established its subsidiary company, MG MED, in 2001 in order to provide medical services based on genetic information. The company specializes in providing hospitals and medical examination centers with services in the area of diagnosing various contagious (infectious) diseases, including the HPV, using its own genetic analysis technology.
In addition to providing diagnoses of contagious(infectious) diseases ? the most active of the molecular diagnostic fields ? MG MED also provides services in diagnosing chromosomal abnormalities using MACROGEN BAC chips, for which the KFDA has granted a regulatoryn approval as an IVD testal for marketing. The company’s future business portfolio is to span all areas of genetic testing, including genetic diagnoses of diseases and molecular diagnoses such as drug sensitivity tests. Such a business portfolio will help the company pioneer the future market of both disease diagnoses and disease prevention by securing stable income structure.
|
| |
MGenbio is a venture corporation created by co-investments of MACROGEN and Sunjin in 2002 for specialization in organ transplantation. Within a year of the foundation, the company succeeded in producing 'Hyeong-gwang-yi', a pig cloned for transformation, thereby establishing itself in the area of cloning and transforming technologies.
The areas of MGenbio's specialization are the development of bio-organs and the production of the high-end protein products for medical treatment. MGenbio, which has succeeded in cloning pigs possessing human immune genes for the treatment of diabetes and (for providing supplements for anticancer treatments through augmenting white blood cells) (for providing growth factors of white blood cells for supplementary anti-cancer treatement), is an active leader in its field. In June, 2006, the company also merged with Sangsaengwon Inc., the top producer of goat milk in Korea, in order to secure an income source necessary to sustain long-term research and development of the bio-organs and protein medicines. The company, thus, has secured a stable ground for success.
|
| |
 |
| |
Business overview |
1. Develop medical
treatment cells and tissues and heterogeneous organs |
2.
Develop protein medicine using nuclear transplant/transformation
technologies |
| 3. Business related
to disease treatment and prevention |
| 4.
Production of dewy goat milk |
| 5.
Diagnosis reagent and individual gene tracking business |
|
| |
 |
| Major Publication |
|
|
Production of nuclear transfer-derived
swine that express the enhanced green fluorescent
protein.
(Anim Biotech 2001; 12:173-181.) |
|
Production of (1, 3) Galactosyltransferase
Knockout Pigs by Nuclear Transfer Cloning
(Science, 2002 ; 295:1089-1092) |
|
 |
|
|
| |
|
